Works matching AU Qian, Hongjie
Results: 10
Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide (SHR20004), a novel GLP‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 816, doi. 10.1111/dom.16080
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin‐A receptor antagonist.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13750
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and food effect of sudapyridine (WX‐081), a novel anti‐tuberculosis candidate in healthy Chinese subjects.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13718
- By:
- Publication type:
- Article
A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 9, p. 1704, doi. 10.1111/cts.13584
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 5, p. 810, doi. 10.1111/cts.13490
- By:
- Publication type:
- Article
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 2947, doi. 10.2147/DDDT.S308610
- By:
- Publication type:
- Article
Heart failure in hospitalized patients with diabetic foot ulcers: Clinical characteristics and their relationship with prognosis (糖尿病足溃疡住院患者的心衰：临床特点以及它们与预后的关系)
- Published in:
- Journal of Diabetes, 2013, v. 5, n. 4, p. 429, doi. 10.1111/1753-0407.12062
- By:
- Publication type:
- Article
A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 465, doi. 10.1007/s00280-021-04297-z
- By:
- Publication type:
- Article
Seismic Response and Safety Assessment of an Existing Concrete Chimney under Wind Load.
- Published in:
- Shock & Vibration, 2018, p. 1, doi. 10.1155/2018/1513479
- By:
- Publication type:
- Article
An In Silico Platform to Predict Cardiotoxicity Risk of Anti-tumor Drug Combination with hiPSC-CMs Based In Vitro Study.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 2, p. 247, doi. 10.1007/s11095-023-03644-4
- By:
- Publication type:
- Article